Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:14 PM
Ignite Modification Date:
2025-12-24 @ 2:14 PM
NCT ID:
NCT01042795
Eligibility Criteria:
Inclusion Criteria:
* Histologic diagnosis of bladder carcinoma (\>50% urothelial carcinoma)
* Prior treatment with at least one cycle of platin-based neoadjuvant chemotherapy
* Prior treatment with radical cystectomy revealing pT3NxM0 or pTanyN+M0
* ECOG performance status of 0-1 (Appendix 2).
* No evidence of metastases within 4 weeks of registration
* Adequate organ and marrow function obtained within 14 days of registration
Exclusion Criteria:
* Severe or uncontrolled acute or chronic medical or psychiatric condition
* Prior antiangiogenic therapy
* Prior pelvic radiation for bladder cancer
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01042795
Study Brief:
Protocol Section:
NCT01042795